1. Home
  2. NERV vs MWG Comparison

NERV vs MWG Comparison

Compare NERV & MWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NERV
  • MWG
  • Stock Information
  • Founded
  • NERV 2007
  • MWG 1988
  • Country
  • NERV United States
  • MWG Singapore
  • Employees
  • NERV N/A
  • MWG N/A
  • Industry
  • NERV Biotechnology: Pharmaceutical Preparations
  • MWG Miscellaneous manufacturing industries
  • Sector
  • NERV Health Care
  • MWG Consumer Discretionary
  • Exchange
  • NERV Nasdaq
  • MWG Nasdaq
  • Market Cap
  • NERV 14.6M
  • MWG 14.0M
  • IPO Year
  • NERV 2014
  • MWG 2023
  • Fundamental
  • Price
  • NERV $3.73
  • MWG $0.27
  • Analyst Decision
  • NERV Hold
  • MWG
  • Analyst Count
  • NERV 1
  • MWG 0
  • Target Price
  • NERV $4.00
  • MWG N/A
  • AVG Volume (30 Days)
  • NERV 8.7M
  • MWG 96.6K
  • Earning Date
  • NERV 11-05-2025
  • MWG 11-18-2025
  • Dividend Yield
  • NERV N/A
  • MWG N/A
  • EPS Growth
  • NERV N/A
  • MWG N/A
  • EPS
  • NERV N/A
  • MWG N/A
  • Revenue
  • NERV N/A
  • MWG $31,066,000.00
  • Revenue This Year
  • NERV N/A
  • MWG N/A
  • Revenue Next Year
  • NERV N/A
  • MWG N/A
  • P/E Ratio
  • NERV N/A
  • MWG N/A
  • Revenue Growth
  • NERV N/A
  • MWG N/A
  • 52 Week Low
  • NERV $1.15
  • MWG $0.21
  • 52 Week High
  • NERV $12.46
  • MWG $0.39
  • Technical
  • Relative Strength Index (RSI)
  • NERV 51.45
  • MWG 41.34
  • Support Level
  • NERV $3.50
  • MWG $0.28
  • Resistance Level
  • NERV $4.00
  • MWG $0.30
  • Average True Range (ATR)
  • NERV 0.95
  • MWG 0.01
  • MACD
  • NERV -0.13
  • MWG -0.00
  • Stochastic Oscillator
  • NERV 11.92
  • MWG 17.74

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.

About MWG Multi Ways Holdings Limited

Multi Ways Holdings Ltd is a supplier of a wide range of heavy construction equipment for sales and rental in Singapore and the surrounding region. The wide variety of new and used heavy construction equipment for sale and rental by customers range from: earth-moving equipment such as bulldozers, off-terrain dump trucks, excavators and wheel loaders; material-handling equipment such as crawler cranes, rough terrain cranes, scissor lifts, forklifts, boom-lifts and telescopic handlers; road-building equipment such as motor graders, vibrating compactors, asphalt finishers, skid loaders, backhoe loaders, hand rollers and mini excavators; and generators and compressors, such as air compressors, generators, lighting towers and welding machines.

Share on Social Networks: